Skip to Main content Skip to Navigation
Journal articles

Small molecule regulated sgRNAs enable control of genome editing in E. coli by Cas9

Abstract : CRISPR-Cas9 has led to great advances in gene editing for a broad spectrum of applications. To further the utility of Cas9 there have been efforts to achieve temporal control over its nuclease activity. While different approaches have focused on regulation of CRISPR interference or editing in mammalian cells, none of the reported methods enable control of the nuclease activity in bacteria. Here, we develop RNA linkers to combine theophylline-and 3-methylxanthine (3MX)-binding aptamers with the sgRNA, enabling small molecule-dependent editing in Escherichia coli. These activatable guide RNAs enable temporal and post-transcriptional control of in vivo gene editing. Further, they reduce the death of host cells caused by cuts in the genome, a major limitation of CRISPR-mediated bacterial recombineering.
Complete list of metadatas

Cited literature [40 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02511866
Contributor : Myriam Bodescot <>
Submitted on : Thursday, March 19, 2020 - 10:27:41 AM
Last modification on : Tuesday, October 20, 2020 - 1:44:50 PM
Long-term archiving on: : Saturday, June 20, 2020 - 1:39:12 PM

File

s41467-020-15226-8.pdf
Publication funded by an institution

Identifiers

Collections

Citation

Roman Iwasaki, Bagdeser Ozdilek, Andrew Garst, Alaksh Choudhury, Robert Batey. Small molecule regulated sgRNAs enable control of genome editing in E. coli by Cas9. Nature Communications, Nature Publishing Group, 2020, 11 (1), pp.1394. ⟨10.1038/s41467-020-15226-8⟩. ⟨inserm-02511866⟩

Share

Metrics

Record views

309

Files downloads

803